Quince Therapeutics, Inc. (QNCX): 8-K/A filed Jul 30, 2026

Form type

8-K/A

Filing date

Jul 30, 2026

Accession number

0001193125-26-324786

Filer

Quince Therapeutics, Inc. (CIK 1662774)